Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Ovarian Neoplasms and MUT[original query] |
|---|
| Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. International journal of cancer. Journal international du cancer 2003 Sep 106 (4): 588-93. de Sanjosé Silvia, Léoné Mélanie, Bérez Victoria, Izquierdo Angel, Font Rebeca, Brunet Joan M, Louat Thierry, Vilardell Loreto, Borras Joan, Viladiu Pau, Bosch F Xavier, Lenoir Gilbert M, Sinilnikova Olga |
| Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 May 26 (5): 914-20. Monk B J, Ghatage P, Parekh T, Henitz E, Knoblauch R, Matos-Pita A S, Nieto A, Park Y C, Cheng P S, Li W, Favis R, Ricci D, Poveda |
| Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study). ESMO open 2021 7 6 (4): 100212. Perez-Fidalgo J A, Cortés A, Guerra E, García Y, Iglesias M, Bohn Sarmiento U, Calvo García E, Manso Sánchez L, Santaballa A, Oaknin A, Redondo A, Rubio M J, González-Martín |
| Establishment and validation of an immune infiltration predictive model for ovarian cancer. BMC medical genomics 2023 9 16 (1): 227. Zhenxia Song, Jingwen Zhang, Yue Sun, Zhongmin Jiang, Xiaoning L |
| Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival. Gynecologic oncology 2023 12 180 35-43. Ryan M Kahn, Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Y Sia, Anna Maio, Yelena Kemel, Margaret Sheehan, Erin Salo-Mullen, Kelsey E Breen, Qin Zhou, Alexia Iasonos, Rachel N Grisham, Roisin E O'Cearbhaill, Dennis S Chi, Michael F Berger, Ritika Kundra, Nikolaus Schultz, Lora H Ellenson, Zsofia K Stadler, Kenneth Offit, Diana Mandelker, Carol Aghajanian, Dmitriy Zamarin, Paul Sabbatini, Britta Weigelt, Ying L L |
| Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 1 . Landen Charles N, Molinero Luciana, Hamidi Habib, Sehouli Jalid, Miller Austin, Moore Kathleen N, Taskiran Cagatay, Bookman Michael, Lindemann Kristina, Anderson Charles, Berger Regina, Myers Tashanna, Beiner Mario, Reid Thomas, Van Nieuwenhuysen Els, Green Andrew, Okamoto Aikou, Aghajanian Carol, Thaker Premal H, Blank Stephanie V, Khor Victor K, Chang Ching-Wei, Lin Yvonne G, Pignata Sand |
| BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer. Clinical epigenetics 2024 11 16 (1): 171. Heidelinde Fiegl, Simon Schnaiter, Daniel U Reimer, Katharina Leitner, Petra Nardelli, Irina Tsibulak, Verena Wieser, Katharina Wimmer, Esther Schamschula, Christian Marth, Alain G Zeim |
| Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics. Cancers 2024 1 16 (1): . Qian Xi, Hidenori Kage, Miho Ogawa, Asami Matsunaga, Akira Nishijima, Kenbun Sone, Kei Kawana, Katsutoshi O |
- Page last reviewed:Feb 1, 2024
- Content source: